0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  ONLINE FIRST
Donovan T. Maust, MD, MS; Hyungjin Myra Kim, ScD; Lisa S. Seyfried, MD, MS; et al.
JAMA Psychiatry. Published online March 18, 2015. doi:10.1001/jamapsychiatry.2014.3018

Viewpoint | 
Yuhua Bao, PhD; Yan Tang, MS; Julie Donohue, PhD
JAMA Psychiatry. 2015;72(3):201-202. doi:10.1001/jamapsychiatry.2014.2186.

Research Letter |  ONLINE FIRST
Stacey C. Sigmon, PhD
JAMA Psychiatry. Published online February 11, 2015. doi:10.1001/jamapsychiatry.2014.2421

Editorial | 
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry. 2015;72(2):110-111. doi:10.1001/jamapsychiatry.2014.2190.

Original Investigation | 
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Psychiatry. 2015;72(2):136-142. doi:10.1001/jamapsychiatry.2014.1763.
Includes: Supplemental Content

Original Investigation | 
Theodore J. Cicero, PhD; Matthew S. Ellis, MPE; Hilary L. Surratt, PhD; et al.
JAMA Psychiatry. 2014;71(7):821-826. doi:10.1001/jamapsychiatry.2014.366.
Includes: CME

Original Article |  FREE
Mark Olfson, MD, MPH; Steven C. Marcus, PhD
Arch Gen Psychiatry. 2009;66(8):848-856. doi:10.1001/archgenpsychiatry.2009.81.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Viewpoint  | 
The Cost and Value of Anti–Epidermal Growth Factor Receptor Therapies:  Let's Not Be Rash
Leonard B. Saltz, MD
JAMA Internal Medicine
Invited Commentary  | 
Evidence-Based Deprescribing of Statins in Patients With Advanced Illness
Holly M. Holmes, MD, MS; Adam Todd, PhD, MPharm
JAMA Internal Medicine
Original Investigation  | 
Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness:  A Randomized Clinical Trial
Jean S. Kutner, MD, MSPH; Patrick J. Blatchford, PhD; Don H. Taylor, PhD; et al.
JAMA Internal Medicine
Special Communication  | 
Reducing Inappropriate Polypharmacy:  The Process of Deprescribing
Ian A. Scott, MBBS, FRACP, MHA, MEd; Sarah N. Hilmer, MBBS, FRACP, PhD; Emily Reeve, BPharm (Hons), PhD; et al.